Abstract: BACKGROUND: Inflammatory bowel disease (IBD) starting during childhood has been assumed to impair quality of life (QoL) of affected children. As this aspect is crucial for further personality development, the health-related quality of life (HRQOL) was assessed in a Swiss nationwide cohort to obtain detailed information on the fields of impairment. METHODS: Data were prospectively acquired from pediatric patients included in the Swiss IBD Cohort Study. IBD activity was evaluated by PCDAI and PUCAI. The age adapted KIDSCREEN questionnaire was evaluated for 110 children with IBD (64 with Crohn's disease 46 with ulcerative colitis). Data were analyzed with respect to established reference values of healthy controls. RESULTS: In the KIDSCREEN index a moderate impairment was only found for physical wellbeing due to disease activity. In contrast, mental well-being and social support were even better as compared to control values. A subgroup analysis revealed that this observation was restricted to the children in the German speaking part of Switzerland, whereas there was no difference compared to controls in the French part of Switzerland. Furthermore, autonomy and school variables were significantly higher in the IBD patients as compared to controls. CONCLUSIONS: The social support for children with IBD is excellent in this cohort. Only physical well-being was impaired due to disease activity, whereas all other KIDSCREEN parameters were better as compared to controls. This indicates that effective coping and support strategies may be able to compensate the burden of disease in pediatric IBD patients. • Inflammatory bowel disease (IBD) impacts the quality of life (QoL) in pediatric patients.
What is known about this topic?
• Inflammatory bowel disease (IBD) impacts the quality of life (QoL) in pediatric patients.
• Pediatric IBD patients may have difficulties with school, inability to participate in physical activities decreased social competences.
• Pediatric patients with IBD are at risk for depression, anxiety, social isolation, and altered self-image, which can negatively affect health-related quality of life (HRQOL)
What this study adds
• In the KIDSCREEN index only a moderate impairment of children with IBD found for physical well-being in the Swiss cohort study.
• Mental well-being and social support were not different or even better than control values, indicating that depression and emotional impairment were not more abundant in paediatric IBD patients of this cohort.
• Autonomy and school variables were significantly higher in the paediatric IBD patients in this Swiss cohort.
Introduction
Inflammatory bowel diseases (IBD), which include Crohn's disease (CD) and ulcerative colitis (UC) as well as unclassified IBD, are chronic and sometimes disabling diseases with unpredictable courses and difficult treatment. Epidemiological studies report high and rising incidence of childhood IBD in Western and Northern Europe, in North America and in Asia [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] .
Therapy for IBD has rapidly evolved during recent years with the introduction of novel therapies and treatments. Some of these new treatments are expensive and their benefit/risk ratio has to be carefully evaluated. On the other hand, the impact of those new therapies on patient quality of life (QoL) is often considerable. Paediatric IBD patients are affected by a number of problems that are not restricted to the gastrointestinal tract [9, [11] [12] [13] . When these chronic diseases manifest during childhood or adolescence, which is obviously a critical developmental period, the transition to adulthood can be impaired by physical but also by psychological factors [14] . Paediatric patients with severe IBD, particularly CD, frequently suffer from malnutrition, growth failure and pubertal delay at the time of diagnosis [15] [16] [17] [18] .
Furthermore, self-reported difficulties with school absenteeism, inability to participate in physical activities [19, 20] and parental-reported decreased social competences [21] [22] [23] have been reported.
It is known that -similar to other chronic diseases of childhood and adolescencepatients with IBD are at risk for depression, anxiety, social isolation, and altered selfimage, which can negatively affect health-related quality of life (HRQOL) [14, [24] [25] [26] [27] .
Identifying patients with impaired quality of life is of importance, as it may change treatment strategies [14, 27] .
In 2006 a nationwide cohort study on patients with IBD in Switzerland, the Swiss IBD Cohort Study (SIBDCS), was initiated [28] . The general aim of the SIBDCS is to provide the Swiss and international scientific, public health and medical community information on a disease-oriented prospective cohort of inflammatory bowel disease patients. Data from the Swiss IBD cohort (SIBDC) represent up-to date epidemiological data (e.g. prevalence, incidence, clinical course of IBD) [28] . In the paediatric sub-cohort, the Swiss Paediatric IBD cohort study (SPIBDCS), quality of life and psychological adjustment has been evaluated by the KIDSCREEN questionnaire. So far it was not clear how this score is associated with characteristics of the disease and demographic variables. The purpose of this project was to examine medical, individual and demographic determinants of health-related quality of life in children and adolescents with IBD. We hypothesized that in a wellfunctioning health system the impact of IBD on HRQoL is limited and coping can support an almost normal mental well-being in paediatric IBD patients.
To challenge our hypothesis the KIDSCREEN results of 110 children in the cohort were correlated with medical factors of potential impact such as disease activity (PCDAI, PUCAI), surgery, complications, and disease duration. In addition, individual factors of the patient (such as age, gender, education, and migratory background) were analyzed.
Materials and Methods

Patients
Since 2006, 2530 adult and pediatric IBD patients from all regions of Switzerland have been included into the nationwide Swiss IBD Cohort Study that is supported by the Swiss National Science Foundation (SNF) and approved by the local ethics committees [28] . Informed consent was obtained from parents and/or patients. At the time of inclusion, patients underwent a thorough clinical and laboratory assessment including calculation of clinical IBD disease activity scores (including PCDAI and PUCAI for paediatric patients). Data acquisition focused on clinical, socio-economic and psychosocial data. 110 paediatric patients were available for analysis. Data quality was assessed by internal review.
Definitions
We retrieved data from the registry including demographic items (age and level of education at diagnosis, parental age, level of education and economical status at diagnosis, siblings and their age and level of education at diagnosis, as well as the medical, social and migratory family history), IBD disease factors (disease extension, inflammatory activity, complications, current medication, past therapeutic interventions, growth and puberty, co-morbidity) as well as data from these activity indices:
The Paediatric Crohn's Disease Activity Index (PCDAI) is a reliable and valid 8-item measure designed to assess disease activity in paediatric patients with CD. It takes into account patient history and the following laboratory data: complete blood count (CBC), erythrocyte sedimentation rate (ESR), and albumin. Scores range from 0-100, with ≤10 indicating inactive disease, 11-30 indicating mild disease, and >30 indicating moderate-to severe disease [29, 30] .
The Paediatric Ulcerative Colitis Activity Index (PUCAI) is a validated, non-invasive, 6-item measure of disease activity with established cut-off values for remission (<10 points), mild (10-34 points), moderate (35-64 points), and severe disease (65-85 points). The index takes into account stool frequency, stool consistency, presence of bloody stools, nocturnal stools, abdominal pain, and patient activity level [31] .
Questionnaires
The KIDSCREEN-27 is a Quality of life Questionnaire consisting of 27 items measuring physical well-being, psychological well-being, autonomy and parent relations, peers and social support, and school environment. The KIDSCREEN-27 was developed as a shorter version of the KIDSCREEN-52 with good psychometric properties [32] . Each of the 27 items is rated as being not true (0), somewhat true (1), balanced (2), rather true (3) or certainly true (4) . Interscale correlation range from 0.36 to 0.59 (0.33-0.57) for the self-report (proxy report) [33, 34] . The KIDSCREEN has been validatet in a large study involving 3988 children and 2526 child-proxy pairs in seven European countries (Austria, Switzerland, Germany, Spain, France, United Kingdom, and the Netherlands) [32] .
Sociodemographic information
Sociodemographic information included age and gender of the child, language of the survey (French speaking part of Switzerland versus German speaking part), migration status of the child, education, parental education and socioeconomic status.
Statistical Analysis
Clinical data were retrieved from the data centre of the SIBDCS at the University of In the UC population, 3.3% had proctitis only, 15.0% had left sided colitis and 76.7% had pancolitis. This is in accordance with other reports indicating a higher percentage of pancolitis in paediatric UC patients [35] [36] [37] [38] [39] . Active disease at time of enrolment visit (PCDAI > 150 or PUCAI ≥ 10) was noted in 39.5% of patients with CD and 37.3% of patients with UC, respectively. Active disease at time of KIDSCREEN interview was noted in 35.7% of patients with CD and 28.0% of patients with UC. It needs to be mentioned that enrolment questionnaire (physician visit) and KIDSCREEN interview were not necessarily carried out at the same time point.
However, 81/110 KIDSCREEN interview were made within +/-10 days of enrolment visit. The medical therapy of all pediatric CD and UC patients at the time of the survey is summarized in table 2. It indicates that 70.0% patients with UC and 24.1% of patients with CD were currently treated with 5-ASA (p-value < 0.001). We also observed a small statistically not significant difference for Infliximab treatment (19.3% in CD vs 8.3% in UC, p-value = 0.068) and for no current therapy at all (3.6% in CD vs 11.7% in UC; p-value = 0.062). Use of adalimumab treatment was very rare, as well as combination therapies involving immunosuppressants and anti-TNF agents.
HRQoL in the total sample
In general, children and adolescents with IBD reported a lower score for physical well being as compared to their healthy peers (table 3) . However, the difference was not statistically significant. We did not observe a difference between patients with CD and UC. Furthermore, physical well-being seemed not to be affected by history of surgery (47.8 ± 12.1 vs 47.7 ± 10.2, p-value = 0.973). In addition, we could not find a statistically significant difference between CD patients with purely inflammatory behavior (B1 only) and CD patients with more complicated behavior (B2 and/or B3) for the mentioned parameters. However, there was a clear trend for a better score (p = 0.069) for physical well-being in the children with B1 disease behaviour. The same was found for the comparison between CD Patients with and without perianal disease. Whereas in general scores were very similar there was a trend for a better score in CD patients without perianal disease for physical well-being (p = 0.099) (table 3) . It is noteworthy that mental well-being was not affected at all by the disease behaviour. Surprisingly also no difference between patients with active disease and patients in remission was detected.
In contrast, surprisingly the mental well-being was found to be significantly higher in the IBD patients as compared to healthy controls (IBD patients: 53.4 ± 10.7 vs controls: 50.0 ± 10.0, p-value = 0.001). A significant difference could also be found with respect to parents/autonomy (54.4 ± 11.7 vs 50.00 ± 10.00, p-value < 0.001), which was higher in paediatric IBD patients as compared to healthy controls. We found no difference between CD and UC patients with respect to these parameters.
While parents/autonomy scores were not different between patients free-of-surgery and patients with a past surgical procedure, we could observe significant difference for the mental well-being score (no surgery: 52.7 ± 10.5 vs surgery 59.6 ± 11.4, pvalue = 0.043).
For social support in the total cohort, a statistically significant difference again could be found between IBD patients and controls (54.8 ± 10.6 vs 50.0 ± 10.0, p-value < 0.001). There was no difference between CD and UC patients, as well as surgeryfree patients vs patients with a positive surgery history.
Similar to what we found for parents' support and social support the values for selfevaluation of school performance were even higher in the IBD cohort as compared to healthy children (53.3 ± 10.4 vs 50.00 ± 10.00, p-value = 0.001). Again this did not differ between CD vs UC patients. The history of surgery had no impact on this finding.
Disease duration was not found to be a statistically significant factor for any of the KIDSCREEN subscores. We observed a negative association of disease duration On the contrary, young and old teenagers showed significantly higher mental, parental, social and school scores compared to control group, but physical well being was not statistically different from the control group, although lower in mean.
Discussion
The present paper demonstrates in a large cohort of paediatric IBD patients the impact of the disease on HRQoL. To our knowledge, this is one of the first studies It would further support the concept that mental and social HRQoL scores are not impaired in the paediatric IBD patients in our cohort.
Previous evaluations of the KIDSCREEN score have shown that children aged 8-11 score higher than adolescents aged 12-18 on the self-report and parent-report version [42] . In addition, girls had a trend to slightly lower scores, which was only significant in the 8 -11 years age-group. In our cohort we could not find any significant gender difference in any age group. In contrast the numbers were even higher (but not significant) for all parameters among the female patients (figure 1).
In contrast to previous studies we could not find an impaired mental well-being in our patients. Engstrom et al. had reported that parents of paediatric IBD patients had significantly lower scores on a social support scale [43] . The mental health of the children with IBD correlated with the social support [43] . On the other hand Engstrom already found that HRQoL in paediatric IBD patients is not only dependent on the course of the intestinal inflammation but also on the psychological and social support and situation [44] . With respect to those findings we conclude from our data that good social support may enable paediatric IBD patients to completely cope with their symptoms. This further underlines the importance of social support and good coping strategies. There was only a minor impact of the socioeconomic background of the patients.
Our results with respect to the impact of surgery on HRQoL also are in contrast to other reports: Casellas and co-workers compared 29 CD patients in remission with previous bowel resections to 42 clinically active CD patients and 48 patients with medically induced remission with respect to HRQoL measured by Inflammatory Bowel Disease Questionnaire (IBDQ), the Psychological General Well Being Index (PGWBI), and the EuroQol. They found that both operated and non-operated inactive CD patients had lower HRQOL scores than controls [45] . Emotional, social, or functional dimensions did not differ significantly between operated and non-operated inactive CD patients [45] . They conclude that HRQoL is impaired in active CD, and improves during remission irrespective of whether it had been achieved medically or surgically [45] . While we also did not detect significant differences for parents/autonomy scores between free-of-surgery patients and patients with a past surgical procedure, the patients that had undergone surgery had a significantly better mental well-being score.
In line with our findings are studies reporting that steroid exposure, hospitalizations, and time from IBD diagnosis do not significantly impact on HRQoL in paediatric IBD [46] .
Our study has strengths and limitations. One strength is the cohort design evaluating the health related quality of life in a large proportion of paediatric Swiss IBD patients.
The quality of the data is robust. A possible limitation may be that a selection bias occurred as mainly patients from representative university hospitals and less from private practices have been included. However, it can be assumed that paediatric patients treated in private practice have less health impairments and that a predominance of clinic patients may -if at all -introduce a bias towards more severe disease and consecutively more impairment of the health related quality of life. In addition only few children with IBD are cared for in private practice contrary to the adult patient with IBD. Another limitation may be the instrument used here, the KIDSCREEN index. While most children deny in questionnaires or interviews that IBD interferes with their lives, with persistent questioning many admit frustration and anger about their IBD symptoms and treatment [14, 47] . Further, the question, whether a statistical significant difference in the KIDSCREEN represents a clinically important difference is difficult to answer. Indeed many of the scores were quite close.
In conclusion, our cohort study demonstrates that mental well-being, social support as well as school performance are excellent in the paediatric Swiss IBD cohort.
HRQoL does not necessarily need to be impaired in children with IBD as long as coping strategies are effective. Tables   Table 1 Clinical characteristics of the whole cohort of paediatric patients of the SIBDC.
Active Disease was defined as PCDAI > 150 for CD and PUCAI >= 10 for UC. 
CD
